Compare · HAE vs MMM
HAE vs MMM
Side-by-side comparison of Haemonetics Corporation (HAE) and 3M Company (MMM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HAE and MMM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $92.29B, about 18.6x HAE ($4.95B).
- Over the past year, HAE is up 96.3% and MMM is up 14.9% - HAE leads by 81.5 points.
- HAE has been more active in the news (7 items in the past 4 weeks vs 5 for MMM).
- Both have 25 recent analyst ratings on file.
- Company
- Haemonetics Corporation
- 3M Company
- Price
- $108.42-0.34%
- $179.00+0.02%
- Market cap
- $4.95B
- $92.29B
- 1M return
- +37.87%
- +3.69%
- 1Y return
- +96.34%
- +14.86%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NYSE
- IPO
- 1991
- News (4w)
- 7
- 5
- Recent ratings
- 25
- 25
Haemonetics Corporation
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Latest HAE
- AZENTA ANNOUNCES LEADERSHIP TRANSITION
- Haemonetics Corporation filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form S-8 filed by Haemonetics Corporation
- SEC Form 10-Q filed by Haemonetics Corporation
- Haemonetics Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website
- New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
- Director Madaus Martin D was granted 2,538 shares (SEC Form 4)
- Director Zane Ellen M was granted 2,538 shares, increasing direct ownership by 13% to 21,911 units (SEC Form 4)
- Director Pomeroy Claire was granted 2,538 shares, increasing direct ownership by 15% to 19,410 units (SEC Form 4)
Latest MMM
- 3M Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form 3 filed by new insider George Bobby K
- SEC Form 3 filed by new insider Cunningham Jennifer A.
- 3M Board Declares Quarterly Dividend
- Group President Chavez Rodriguez Beatriz Karina sold $663,430 worth of shares (3,635 units at $182.51), decreasing direct ownership by 21% to 14,035 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by 3M Company
- Sr Vice President & CAO Reinseth Theresa E sold $156,544 worth of shares (924 units at $169.42), decreasing direct ownership by 26% to 2,615 units (SEC Form 4)
- Executive Vice President Banovetz John Patrick exercised 7,880 shares at a strike of $154.69 and sold $1,343,067 worth of shares (7,880 units at $170.44) (SEC Form 4)
- EVP, Chief Legal Off & Secret Rhodes Kevin H exercised 7,669 shares at a strike of $154.69 and sold $1,312,933 worth of shares (7,669 units at $171.20) (SEC Form 4)
- Group President Goralski Christian T Jr exercised 4,902 shares at a strike of $154.69 and sold $835,577 worth of shares (4,902 units at $170.46), decreasing direct ownership by 0.00% to 6,971 units (SEC Form 4)